Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Encouraging complete responses (CRs) with CDK9 inhibitor AZD4573 in patients (pts) with relapsed/refractory (r/r) peripheral T‐cell Lymphoma (PTCL): Early trial analysis
Pier Luigi Zinzani, Tatyana Feldman, Graham P. Collins, Jasmine Zain, Amit Khot, J. S. Kim, Franck Morschhauser, T. M. Kim, Justine E. Roderick, Jeong Lim Yoon, Shringi Sharma, Jamal Saeh, Jianrong Dai, R. Reyes, Richard F. Olsson, Jake Shortt (2023). Encouraging complete responses (CRs) with CDK9 inhibitor AZD4573 in patients (pts) with relapsed/refractory (r/r) peripheral T‐cell Lymphoma (PTCL): Early trial analysis. , 41(S2), DOI: https://doi.org/10.1002/hon.3164_425.
Article161 days agoP1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS
Jake Shortt, Tatyana Feldman, Graham P. Collins, Jasmine Zain, Amit Khot, Jin Seok Kim, Franck Morschhauser, Tae Min Kim, Justine E. Roderick, Jeong Lim Yoon, Shringi Sharma, Jamal Saeh, Jiale Dai, Ruben Reyes, R A Olsson, Pier Luigi Zinzani (2023). P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS. , 7(S3), DOI: https://doi.org/10.1097/01.hs9.0000971460.41693.c0.
Article161 days ago